Motohiko Tokuhisa

Yokohama, 2360004, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Comparative Analysis of Site-Specific N-glycosylation of LAMP1 from Breast Cancer Tissues.

Comparative Analysis of Site-Specific N-glycosylation of LAMP1 from Breast Cancer Tissues.

Journal: Journal of biochemistry

Published: July 14, 2023

Targeted O-glycoproteomics for the development of diagnostic markers for advanced colorectal cancer.

Targeted O-glycoproteomics for the development of diagnostic markers for advanced colorectal cancer.

Journal: Frontiers in oncology

Published: November 22, 2022

Clinical Outcomes of Everolimus Rechallenge in Patients with Pancreatic Neuroendocrine Neoplasms with No Other Treatment Options.

Clinical Outcomes of Everolimus Rechallenge in Patients with Pancreatic Neuroendocrine Neoplasms with No Other Treatment Options.

Journal: Cancers

Published: October 13, 2022

Effectiveness and Prognostic Factors of Everolimus in Patients with Pancreatic Neuroendocrine Neoplasms.

Effectiveness and Prognostic Factors of Everolimus in Patients with Pancreatic Neuroendocrine Neoplasms.

Journal: Internal medicine (Tokyo, Japan)

Published: June 15, 2022

Real-world Therapeutic Outcomes of the Pembrolizumab Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Single-center Retrospective Cohort Study in Japan.

Real-world Therapeutic Outcomes of the Pembrolizumab Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Single-center Retrospective Cohort Study in Japan.

Journal: Anticancer research

Published: May 31, 2022

Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder.

Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder.

Journal: Clinical journal of gastroenterology

Published: February 28, 2022

Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors.

Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors.

Journal: Annals of nuclear medicine

Published: June 23, 2021

Combination of Performance Status and Lymphocyte-monocyte Ratio as a Novel Prognostic Marker for Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.

Combination of Performance Status and Lymphocyte-monocyte Ratio as a Novel Prognostic Marker for Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.

Journal: Cancer diagnosis & prognosis

Published: May 07, 2021

Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors.

Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors.

Journal: Journal of hepato-biliary-pancreatic sciences

Published: April 22, 2021

Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinoma.

Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinoma.

Journal: Cancer science

Published: November 29, 2020

Pathological Findings of the Host Immune Reaction in the Tumor Microenvironment of Gastroenteropancreatic Neuroendocrine Neoplasms.

Pathological Findings of the Host Immune Reaction in the Tumor Microenvironment of Gastroenteropancreatic Neuroendocrine Neoplasms.

Journal: Internal medicine (Tokyo, Japan)

Published: November 09, 2020

Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype.

Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype.

Journal: Frontiers in oncology

Published: April 26, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026